L'Oreal is making human skin in the lab to test products and reduce animal testing. Coming soon: 3-D printed skin for tissue engineering. » Read More
CNBC's Meg Tirrell reports on the biggest health issues and how industry leaders are thinking about the future of health care in America. David Gluckman, Lazard co-head of health care, weighs in. » Read More
By: Alexandra Ossola
Over the course of a year, scientists sampled the microbes in a newly-opened facility in Chicago, Vocativ reports. » Read More
CNBC's Meg Tirrell reports on Puma's stock spike after the FDA board votes in support of its breast cancer drug. » Read More
CNBC's Meg Tirrell reports on the FDA approving Puma Biotech's breast cancer drug, which sent shares of the company higher.
IBM's A.I. star joins Viome, a biotech start-up that tracks a person's microbiome ecosystem with tech born out of Los Alamos National Lab.
Ginkgo Bioworks founder Jason Kelly discusses his company's strides in bio-engineering, earning seventh place on the 2017 CNBC Disruptor 50.
One in 8 couples will experience fertility issues. Progyny believes providing infertility benefits and services will keep employees happy.
A growing appetite for branded drugs in China is expected to offset plunge in prices, Financial Times reports.
CVS shares fall after CNBC reported that Amazon is hiring people to push into the pharmacy business.
ASCO's abstract drop reveals the progress being made in attacking cancer and, inevitably, moves stocks both large and small.
CNBC's Meg Tirrell reports the latest out of Johnson & Johnson's analyst day including the company's growing pharmaceutical business.
Amazon is hiring a business lead to strategize how the company can break into the multibillion-dollar pharmacy market.
Johnson & Johnson contributed the most to gains on the Dow after analysts at JPMorgan upgraded the stock.
Machine learning might help computers diagnose diseases, improve and suggest treatment, and even detect illnesses before they even start.
The full interview with Merck CEO Kenneth Frazier.
The rising price of medicine has led some patients to resort to Facebook for life-saving drugs, NBC News reports.
The increases fit a pattern of drugmakers making single-digit percentage hikes once or twice a year, despite political pressure.
The high cost of health care in the US is nothing compared to the markup on some prescription medicines. We reveal the most expensive drugs.
EpiPen maker Mylan said on Wednesday first-quarter profit more than quadrupled, as the maker of generic drugs benefited from strong demand outside the U.S.
Get the best of CNBC in your inbox